AIMC Topic: Drug Discovery

Clear Filters Showing 711 to 720 of 1558 articles

AI in 3D compound design.

Current opinion in structural biology
The success of Artificial Intelligence (AI) across a wide range of domains has fuelled significant interest in its application to designing novel compounds and screening compounds against a specific target. However, many existing AI methods either do...

Technique of Augmenting Molecular Graph Data by Perturbating Hidden Features.

Molecular informatics
Quantitative structure-property relationship models are useful in efficiently searching for molecules with desired properties in drug discovery and materials development. In recent years, many such models based on graph neural networks, showing good ...

Chemical Reactivity Prediction: Current Methods and Different Application Areas.

Molecular informatics
The ability to predict chemical reactivity of a molecule is highly desirable in drug discovery, both ex vivo (synthetic route planning, formulation, stability) and in vivo: metabolic reactions determine pharmacodynamics, pharmacokinetics and potentia...

Graph neural network approaches for drug-target interactions.

Current opinion in structural biology
Developing new drugs remains prohibitively expensive, time-consuming, and often involves safety issues. Accurate prediction of drug-target interactions (DTIs) can guide the drug discovery process and thus facilitate drug development. Non-Euclidian da...

Turbo prediction: a new approach for bioactivity prediction.

Journal of computer-aided molecular design
Nowadays, activity prediction is key to understanding the mechanism-of-action of active structures discovered from phenotypic screening or found in natural products. Machine learning is currently one of the most important and rapidly evolving topics ...

Mycobacterium abscessus drug discovery using machine learning.

Tuberculosis (Edinburgh, Scotland)
The prevalence of infections by nontuberculous mycobacteria is increasing, having surpassed tuberculosis in the United States and much of the developed world. Nontuberculous mycobacteria occur naturally in the environment and are a significant proble...

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application.

Molecules (Basel, Switzerland)
Most contemporary drug discovery projects start with a 'hit discovery' phase where small chemicals are identified that have the capacity to interact, in a chemical sense, with a protein target involved in a given disease. To assist and accelerate thi...

Transfer inhibitory potency prediction to binary classification: A model only needs a small training set.

Computer methods and programs in biomedicine
One of the most laborious for drug discovery is to select compounds from a library for experimental evaluation. Hence, we propose a machine learning model only needs to be trained on a small dataset to predict the inhibition constant (Ki) and half ma...

Ligand Based Virtual Screening Using Self-organizing Maps.

The protein journal
Conventional drug discovery methods rely primarily on in-vitro experiments with a target molecule and an extensive set of small molecules to choose the suitable ligand. The exploration space for the selected ligand being huge; this approach is highly...

Advancing pharmacy and healthcare with virtual digital technologies.

Advanced drug delivery reviews
Digitalisation of the healthcare sector promises to revolutionise patient healthcare globally. From the different technologies, virtual tools including artificial intelligence, blockchain, virtual, and augmented reality, to name but a few, are provid...